1. Home
  2. COHN vs SCNX Comparison

COHN vs SCNX Comparison

Compare COHN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$10.12

Market Cap

38.7M

Sector

Finance

ML Signal

HOLD

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

HOLD

Current Price

$0.33

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
SCNX
Founded
1999
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Other Pharmaceuticals
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
16.2M
IPO Year
2003
2019

Fundamental Metrics

Financial Performance
Metric
COHN
SCNX
Price
$10.12
$0.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
22.1K
303.8K
Earning Date
05-01-2026
05-13-2026
Dividend Yield
4.35%
N/A
EPS Growth
5537.50
N/A
EPS
1.36
N/A
Revenue
$275,564,000.00
$3,831,778.00
Revenue This Year
N/A
$1,097.38
Revenue Next Year
N/A
$239.80
P/E Ratio
$7.43
N/A
Revenue Growth
246.19
30.72
52 Week Low
$9.19
$0.24
52 Week High
$32.60
$2.60

Technical Indicators

Market Signals
Indicator
COHN
SCNX
Relative Strength Index (RSI) N/A 39.55
Support Level N/A $0.30
Resistance Level N/A $0.43
Average True Range (ATR) 0.00 0.02
MACD 0.00 -0.00
Stochastic Oscillator 0.00 37.33

Price Performance

Historical Comparison
COHN
SCNX

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Share on Social Networks: